Risks of congenital malformations in offspring exposed to valproic acid in utero: A systematic review and cumulative meta-analysis
- PMID: 26044279
- DOI: 10.1002/cpt.158
Risks of congenital malformations in offspring exposed to valproic acid in utero: A systematic review and cumulative meta-analysis
Abstract
Despite extensive research efforts over decades, the teratogenic profile of valproic acid (VPA) remains obscure. We performed cumulative and conventional meta-analyses of cohort studies to determine the time profiles of signal emergence of VPA-associated congenital malformations (CMs) and to define risk estimates of each of the CMs. Fifty-nine studies were identified and analyzed. We found that the significant risk signals began to emerge over the last 10-20 years even before large-scale studies were performed: neural tube defect (the significant risk signal emerged in 1992); genitourinary and musculoskeletal anomalies (2004); cleft lip and/or palate (2005); and congenital heart defects (2006). At present, the risks of VPA-associated CMs are 2-7-fold higher than other common antiepileptic drugs. VPA should not be used as a first-line therapy in women of childbearing age unless it is the only option for the patient.
© 2015, The American Society for Clinical Pharmacology and Therapeutics.
Similar articles
-
Valproic acid monotherapy in pregnancy and major congenital malformations.N Engl J Med. 2010 Jun 10;362(23):2185-93. doi: 10.1056/NEJMoa0907328. N Engl J Med. 2010. PMID: 20558369 Review.
-
Influence of the MTHFR genotype on the rate of malformations following exposure to antiepileptic drugs in utero.Eur J Med Genet. 2007 Nov-Dec;50(6):411-20. doi: 10.1016/j.ejmg.2007.08.002. Epub 2007 Sep 11. Eur J Med Genet. 2007. PMID: 17951123
-
Valproate teratogenicity and epilepsy syndrome.Epilepsia. 2008 Dec;49(12):2122-4. doi: 10.1111/j.1528-1167.2008.01696.x. Epub 2008 Jun 13. Epilepsia. 2008. PMID: 18557775
-
Characterizing the effects of in utero valproic acid exposure on murine fetoplacental development.Placenta. 2021 Sep 1;112:141-152. doi: 10.1016/j.placenta.2021.07.299. Epub 2021 Jul 30. Placenta. 2021. PMID: 34352490
-
Valproic Acid in Women and Girls of Childbearing Age.Curr Psychiatry Rep. 2017 Sep;19(9):58. doi: 10.1007/s11920-017-0809-3. Curr Psychiatry Rep. 2017. PMID: 28726062 Review.
Cited by
-
Prenatal Exposure to Valproic Acid Across Various Indications for Use.JAMA Netw Open. 2024 May 1;7(5):e2412680. doi: 10.1001/jamanetworkopen.2024.12680. JAMA Netw Open. 2024. PMID: 38776082 Free PMC article.
-
Specific Birth Defects Following Antiseizure Medications Used By Pregnant Women With Epilepsy.Neurol Clin Pract. 2024 Jun;14(3):e200289. doi: 10.1212/CPJ.0000000000200289. Epub 2024 Apr 17. Neurol Clin Pract. 2024. PMID: 38720955
-
Valproic Acid in Pregnancy Revisited: Neurobehavioral, Biochemical and Molecular Changes Affecting the Embryo and Fetus in Humans and in Animals: A Narrative Review.Int J Mol Sci. 2023 Dec 27;25(1):390. doi: 10.3390/ijms25010390. Int J Mol Sci. 2023. PMID: 38203562 Free PMC article. Review.
-
Evidence Mapping and Quality Analysis of Systematic Reviews on Various Aspects Related to Cleft Lip and Palate.J Clin Med. 2023 Sep 16;12(18):6002. doi: 10.3390/jcm12186002. J Clin Med. 2023. PMID: 37762942 Free PMC article. Review.
-
Maternal and childhood medical history and the risk of childhood brain tumours: a case-control study in Ontario, Canada.Br J Cancer. 2023 Aug;129(2):318-324. doi: 10.1038/s41416-023-02281-3. Epub 2023 May 10. Br J Cancer. 2023. PMID: 37165200 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
